449 related articles for article (PubMed ID: 30782955)
21. Chlorhexidine gluconate–impregnated central access catheter dressings as a cause of erosive contact dermatitis: a report of 7 cases.
Weitz NA; Lauren CT; Weiser JA; LeBoeuf NR; Grossman ME; Biagas K; Garzon MC; Morel KD
JAMA Dermatol; 2013 Feb; 149(2):195-9. PubMed ID: 23560299
[TBL] [Abstract][Full Text] [Related]
22. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters.
Langgartner J; Linde HJ; Lehn N; Reng M; Schölmerich J; Glück T
Intensive Care Med; 2004 Jun; 30(6):1081-8. PubMed ID: 15085323
[TBL] [Abstract][Full Text] [Related]
23. The use of 3.15% chlorhexidine gluconate/70% alcohol hub disinfection to prevent central line-associated bloodstream infections in dialysis patients.
Marty Cooney R; Manickam N; Becherer P; Harmon LS; Gregg L; Farkas Z; Shea LM; Parekh P; Murphy J; Shade W
Br J Nurs; 2020 Jan; 29(2):S24-S26. PubMed ID: 31972108
[TBL] [Abstract][Full Text] [Related]
24. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, combined or not with use of a bundle of new devices, for prevention of short-term peripheral venous catheter-related infectious complications and catheter failure: an open-label, single-centre, randomised, four-parallel group, two-by-two factorial trial: CLEAN 3 protocol study.
Guenezan J; Drugeon B; O'Neill R; Caillaud D; Sénamaud C; Pouzet C; Seguin S; Frasca D; Mimoz O
BMJ Open; 2019 Apr; 9(4):e028549. PubMed ID: 30944142
[TBL] [Abstract][Full Text] [Related]
25. Protocol of a randomised controlled trial of real-time continuous glucose monitoring in neonatal intensive care 'REACT'.
Beardsall K; Thomson L; Guy C; van Weissenbruch MM; Iglesias I; Muthukumar P; Somisetty SK; Bond S; Petrou S; Dunger D;
BMJ Open; 2018 Jun; 8(6):e020816. PubMed ID: 29866729
[TBL] [Abstract][Full Text] [Related]
26. Polyhexamethylene biguanide discs versus unmedicated dressings for prevention of central venous catheter-associated infection in the intensive care unit: A pilot randomised controlled trial to assess protocol safety and feasibility.
Pearse I; Marsh N; Rickard CM; Ullman AJ; Larsen E; Pelecanos A; McGuinness N; Irvine L; Rapchuk IL; Ziegenfuss M; Corley A
Aust Crit Care; 2022 Sep; 35(5):512-519. PubMed ID: 34321181
[TBL] [Abstract][Full Text] [Related]
27. One percent chlorhexidine-alcohol for preventing central venous catheter-related infection during intensive chemotherapy for patients with haematologic malignancies.
Ohtake S; Takahashi H; Nakagawa M; Uchino Y; Miura K; Iriyama N; Nakayama T; Hatta Y; Takei M
J Infect Chemother; 2018 Jul; 24(7):544-548. PubMed ID: 29627326
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
[TBL] [Abstract][Full Text] [Related]
29. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
[TBL] [Abstract][Full Text] [Related]
30. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant.
Chapman AK; Aucott SW; Milstone AM
J Perinatol; 2012 Jan; 32(1):4-9. PubMed ID: 22031047
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of adding 2% (w/v) chlorhexidine gluconate to 70% (v/v) isopropyl alcohol for skin disinfection prior to peripheral venous cannulation.
Small H; Adams D; Casey AL; Crosby CT; Lambert PA; Elliott T
Infect Control Hosp Epidemiol; 2008 Oct; 29(10):963-5. PubMed ID: 18771405
[TBL] [Abstract][Full Text] [Related]
32. Strategies for the prevention of central venous catheter infections: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review.
Huang EY; Chen C; Abdullah F; Aspelund G; Barnhart DC; Calkins CM; Cowles RA; Downard CD; Goldin AB; Lee SL; St Peter SD; Arca MJ;
J Pediatr Surg; 2011 Oct; 46(10):2000-11. PubMed ID: 22008341
[TBL] [Abstract][Full Text] [Related]
33. Skin antisepsis: using 2% chlorhexidine gluconate in 70% isopropyl alcohol.
Inwood S
Br J Nurs; 2007 Dec 13-2008 Jan 9; 16(22):1390, 1392-4. PubMed ID: 18361387
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of two antiseptic regimens on skin colonization of insertion sites for two different catheter types: a randomized, clinical trial.
Lutz JT; Diener IV; Freiberg K; Zillmann R; Shah-Hosseini K; Seifert H; Berger-Schreck B; Wisplinghoff H
Infection; 2016 Dec; 44(6):707-712. PubMed ID: 27142044
[TBL] [Abstract][Full Text] [Related]
35. Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial.
Sharma A; Kulkarni S; Thukral A; Sankar MJ; Agarwal R; Deorari AK; Mohapatra S; Velpandian T; Bajpai M
Arch Dis Child Fetal Neonatal Ed; 2021 Nov; 106(6):643-648. PubMed ID: 34108192
[TBL] [Abstract][Full Text] [Related]
36. Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better?
Buetti N; Ruckly S; Schwebel C; Mimoz O; Souweine B; Lucet JC; Timsit JF
Crit Care; 2020 Jul; 24(1):458. PubMed ID: 32703235
[TBL] [Abstract][Full Text] [Related]
37. Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial.
Dettenkofer M; Wilson C; Gratwohl A; Schmoor C; Bertz H; Frei R; Heim D; Luft D; Schulz S; Widmer AF
Clin Microbiol Infect; 2010 Jun; 16(6):600-6. PubMed ID: 19686276
[TBL] [Abstract][Full Text] [Related]
38. Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial.
Rickard CM; Marsh NM; Webster J; Gavin NC; Chan RJ; McCarthy AL; Mollee P; Ullman AJ; Kleidon T; Chopra V; Zhang L; McGrail MR; Larsen E; Choudhury MA; Keogh S; Alexandrou E; McMillan DJ; Mervin MC; Paterson DL; Cooke M; Ray-Barruel G; Castillo MI; Hallahan A; Corley A; Geoffrey Playford E
BMJ Open; 2017 Jun; 7(6):e015291. PubMed ID: 28619777
[TBL] [Abstract][Full Text] [Related]
39. Protocol for a randomised controlled trial comparing aqueous with alcoholic chlorhexidine antisepsis for the prevention of superficial surgical site infection after minor surgery in general practice: the AVALANCHE trial.
Heal CF; Charles D; Hardy A; Delpachitra M; Banks J; Wohlfahrt M; Saednia S; Buettner P
BMJ Open; 2016 Jul; 6(7):e011604. PubMed ID: 27388361
[TBL] [Abstract][Full Text] [Related]
40. Treating Parents to Reduce NICU Transmission of Staphylococcus aureus (TREAT PARENTS) trial: protocol of a multisite randomised, double-blind, placebo-controlled trial.
Milstone AM; Koontz DW; Voskertchian A; Popoola VO; Harrelson K; Ross T; Aucott SW; Gilmore MM; Carroll KC; Colantuoni E
BMJ Open; 2015 Sep; 5(9):e009274. PubMed ID: 26353875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
